Pressure Ulcer Diagnostics Market: Introduction
According to the report, the global pressure ulcer diagnostics market was valued at US$ 880.50 Mn in 2020 and is projected to expand at a moderate CAGR from 2021 to 2031. Pressure ulcer diagnostics are devices used in diagnosis and detection of pressure ulcer in adults and elderly patient population.
Pressure ulcers are also called bedsores or pressure injuries. These are caused by pressure on the skin and lead to damage to the underlying skin or tissue. There are four stages of pressure ulcer wounds: stage 1, stage 2, stage 3, and stage 4. Various invasive and non-invasive diagnostic tools are available, which are considered standard method of diagnosis of pressure ulcer. Blood tests are most commonly used for detection of bacteria load and location.
Based on diagnostic test, the global pressure ulcer diagnostics market has been classified into imaging technique, microbiological tests, and others. The imaging technique segment accounted for major market share in 2020 due to adoption of non-invasive tools such as fluorescent imaging, photoacoustic imaging, biomarkers, magnetic resonance, computed tomography, and other imaging technologies. Technological advancements have led to the innovation of new diagnosis techniques, which is expected to drive the segment during the forecast period.
Request Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=82872
Technological Advancements in Diagnosis of Pressure Ulcers to Propel Global Market
Technological advancements are likely to create a paradigm shift in the global pressure ulcer diagnostics market with the introduction of innovative tools for diagnosis and management of the condition. Point-of-care fluorescence imaging techniques are widely adopted and popular in complete visualization of location & presence of bacteria load in the affected areas. This imaging technique is sensitive and direct in identifying the bacteria load in the wound.
Sub-epidermal moisture (SEM) is also considered an effective biomarker for the detection of pressure ulcers. Sub-epidermal moisture enables assessment of the clinical skin & tissue in the patients. SEM is recommended to understand the risk of specific factors in developing pressure ulcers. SEM scanner is a point-of-care device that measures the difference in the skin and the bio capacitance to understand the frequency of developing the pressure ulcer condition.
Request for TOC @
https://www.transparencymarketresearch.com/report-toc/82872
Biomarker is an innovative tool introduced for the assessment of the tissue status in early detection of pressure ulcers. Various studies have proven the significance of biomarkers in the detection of pressure ulcer. Biomarkers are used to monitor skin response to pressure and indicate skin damage.
Pressure Ulcer Diagnostics Market: Prominent Regions
In terms of region, the global pressure ulcer diagnostics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global pressure ulcer diagnostics market in 2020, followed by Europe and Asia Pacific. Increase in patients suffering from pressure ulcers, rise in expenditure of the U.S. Government on management of pressure ulcers, surge in admissions of patients in ICU, and increase in baby boomers in the U.S. propel the market in North America during the forecast period.
The pressure ulcer diagnostics market in Asia Pacific is expected to expand at a higher CAGR from 2021 to 2031. Increase in geriatric patient population at risk of developing pressure ulcers and rise in prevalence of pressure ulcers in ICU admitted patients and long-term care older patients in hospitals and nursing homes are likely to boost the growth of the pressure ulcer diagnostic market in the region over the next few years.
Pre Book Pressure Ulcer Diagnostics Market Report at
https://www.transparencymarketresearch.com/checkout.php?rep_id=82872<ype=S
Product Launch, Innovations by Key Players to Drive Global Market
The global pressure ulcer diagnostics market is consolidated in terms of prominent players. The market is dominated by mid-size companies that focus on implementing strategies such as geographic expansion, launch of innovative products, merger & acquisitions, product expansions, and strategies to expand in developing countries. Key players in the global pressure ulcer diagnostics market include IR-MED, Bruin Biometrics, LLC, Canon Medical Systems Corporation, Esaote SPA, Fonar Corporation, Bruker Corporation, FUJIFILM Healthcare Corporation, GE Healthcare, Arjo, Cyberdyne, Inc., and MolecuLight, Inc.
Strategies adopted by the key players are:
- In May 2021, RCSI and Bruin Biometrics extended their strategic partnership for innovating the pressure ulcer prevention portfolio. The partnership will expand Burin Biometrics' pressure ulcer prevention portfolio.
- In July 2021, Esaote SPA installed its new G-scan Brio unit in Viagrande municipality of Catania, Sicily at Istituto Oncologico del Mediterraneo (IOM). This is an innovative approach, which would enhance the diagnostic capability of the product for various conditions.
More Trending Reports by Transparency Market Research –
Hepatitis Therapeutics Market:
Veterinary Endoscopes Market:
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
